Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Abdominal Neoplasms × Ropivacaine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 16 Breast Neoplasms 15 Pain 9 Agnosia 6 Prostatic Neoplasms 5 Lung Neoplasms 5 Neoplasms 4 Stomach Neoplasms 3 Postoperative Complications 3 Supratentorial Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Sleep Deprivation 1 Sarcoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain, Intractable 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Oropharyngeal Neoplasms 1 Neuroblastoma 1 Neoplasm Metastasis 1 Meningioma 1 Malignant Neoplasms of Male Genital Organs 1 Liver Neoplasms 1 Liver Diseases 1

Interventions

Propofol 2 Dexmedetomidine 2 contrast agent BR1 1 Therapeutics 1 Sevoflurane 1 Ropivacaine 1 Nitrous Oxide 1 Lidocaine 1 Iohexol 1 Glycopyrrolate 1 FS 069 1 Embolization, Therapeutic 1 Drug Therapy 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06430112 2024-05-28

Liposomal Bupivacaine vs Ropivacaine for TAPBs

Sun Yat-sen University

Phase 3 Recruiting

Abdominal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡